Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma

Fig. 2

Identification of m6A-related lncRNAs in patients with PDAC. (A) Sankey diagram demonstrating co-expression relationship between 21 m6A genes and 201 m6A-related lncRNAs. (B) Univariate Cox regression analysis were applied to recognize m6A-related lncRNAs associated with prognosis. (C) Optimal prognosis model was constructed by Lasso regression analysis with tenfold cross validation. (D) Lasso coefficient curve. (E) Multivariate Cox regression analysis was utilized for m6A-related lncRNAs. (F) Heatmap displaying the correlation between 4 lncRNAs and gene associated with m6A. A sequence-based N6-methyladenosine (m6A) modification site predictor of ZNF236-DT (G) and EMSLR (H)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us